+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood



Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood



Journal of Thrombosis and Haemostasis 9(2): 373-382



Patients treated with percutaneous coronary intervention receive aspirin and P2Y12 ADP receptor inhibitors to reduce thrombotic complications. The choice of methodology for monitoring the effects of treatment and assessing its efficacy is still a topic of debate. We evaluated how decreased P2Y12 function influences platelet aggregate (thrombus) size measured ex vivo. We used confocal videomicroscopy to measure in real time the volume of platelet thrombi forming upon blood perfusion over fibrillar collagen type I at a wall shear rate of 1500 s(-1). The average volume was significantly smaller in 31 patients receiving aspirin and clopidogrel (19) or ticlopidine (12) than in 21 controls, but individual values were above the lower limit of the normal distribution, albeit mostly within the lower quartile, in 61.3% of cases. Disaggregation of platelet thrombi at later perfusion times occurred frequently in the patients. Vasodilator-stimulated phosphoprotein phosphorylation, reflecting P2Y12 inhibition, was also decreased in the patient group, and only 22.6% of individual values were above the lower normal limit. We found no correlation between volume of thrombus formed on collagen fibrils and level of P2Y12 inhibition, suggesting that additional and individually variable factors can influence the inhibitory effect of treatment on platelet function. Measurements of platelet thrombus formation in flowing blood reflects the consequences of antiplatelet therapy in a manner that is not proportional to P2Y12 inhibition. Combining the results of the two assays may improve the assessment of thrombotic risk.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056847073

Download citation: RISBibTeXText

PMID: 21083646

DOI: 10.1111/j.1538-7836.2010.04144.x


Related references

Axial dependence of collagen-induced thrombus formation in flowing non-anticoagulated human blood. Anti-platelet drugs impair thrombus growth and increase platelet-collagen adhesion. Thrombosis and Haemostasis 73(1): 126-131, 1995

Glycoprotein Ib alpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thrombosis and Haemostasis 97(3): 435-443, 2007

Effects of pharmacological inhibition of the P2Y1 and P2Y12 ADP receptors on shear-induced platelet aggregation and platelet thrombus formation on a collagen-coated surface under flow conditions. Blood 98(11 Part 1): 239a-240a, 2001

Axial dependence of platelet-collagen interactions in flowing blood. Upstream thrombus growth impairs downstream platelet adhesion. Arteriosclerosis 9(1): 33-42, 1989

Platelet adhesion and platelet thrombus formation on subendothelium of human arteries and veins exposed to flowing blood in vitro. A comparison with rabbit aorta. Haemostasis 8(1): 19-29, 1979

In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability. Arteriosclerosis Thrombosis and Vascular Biology 23(3): 518-523, 2003

P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. Journal of Clinical Investigation 112(3): 398-406, 2003

A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist. Journal of Pharmacology and Experimental Therapeutics 339(1): 54-61, 2011

Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood. Arteriosclerosis Thrombosis and Vascular Biology 22(4): 686-691, 2002

Importance of adenosine 5-diphosphate receptor P2Y12 stimulation in three-dimensional platelet thrombus growth on the collagen surface under blood flow conditions. European Heart Journal 24(Abstract Suppl.): 321, August-September, 2003

Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 103(4): 1333-1341, 2004

Dimers of beta2-glycoprotein I induce increased platelet adhesion and thrombus formation in flowing blood. Lupus 11(9): 553, 2002

Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function. Thrombosis and Haemostasis 103(6): 1210-1217, 2010

Thrombin plays a key role in late platelet thrombus growth and/or stability. Effect of a specific thrombin inhibitor on thrombogenesis induced by aortic subendothelium exposed to flowing rabbit blood. Arteriosclerosis and Thrombosis 14(9): 1466-1474, 1994

The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor. Thrombosis and Haemostasis 103(2): 379-386, 2010